Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614432 · ClinicalTrials.gov registry record
Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women
A clinical trial, sponsored by University of Hawaii.
- Completed
- Registry status
- 10
- Enrollment target
NCT00614432: Completed study, sponsored by University of Hawaii.
NCT00614432 is a clinical trial that has completed, run by University of Hawaii. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00614432 has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.
Primary Outcome
Quantitative blood loss using volume measurement and weight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-04 |
What the finished NCT00614432 record still lists
NCT00614432 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00614432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00614432 about?
NCT00614432 is a clinical study titled "Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women". The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy doe...
What is the current status of trial NCT00614432?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-01. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00614432?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia